| Verona Pharma plc VRNA | $13.16M | 8.07 | 817,833 | +45.05% | +$4.09M | 2.34 | |
| NextCure, Inc. NXTC | $3.03M | 4.86 | 1.36M | New | +$3.03M | 0.54 | |
| Inozyme Pharma, Inc. INZY | $20.24M | 4.27 | 2.64M | +40.13% | +$5.8M | 3.6 | |
| Rezolute, Inc. RZLT | $4.08M | 3.99 | 1.6M | New | +$4.08M | 0.73 | |
| Elevation Oncology, Inc. ELEV | $6.51M | 2.32 | 1.27M | New | +$6.51M | 1.16 | |
| Astria Therapeutics, Inc. ATXS | $11.9M | 1.54 | 845,606 | -42.34% | -$8.74M | 2.11 | |
| COMPASS Pathways plc CMPS | $8.55M | 1.5 | 1.03M | +86.89% | +$3.98M | 1.52 | |
| Nurix Therapeutics, Inc. NRIX | $11.91M | 1.37 | 810,253 | +17.41% | +$1.77M | 2.12 | |
Autolus Therapeutics plc AUTL | $21.53M | 1.27 | 3.38M | +117.69% | +$11.64M | 3.82 | |
| Xenon Pharmaceuticals Inc. XENE | $36.05M | 1.11 | 837,387 | +82.04% | +$16.25M | 6.4 | |
Spyre Therapeutics, Inc. SYRE | $15.55M | 1.02 | 410,000 | -20.78% | -$4.08M | 2.76 | |
Apogee Therapeutics, Inc. APGE | $39.34M | 1.01 | 592,093 | +10.24% | +$3.65M | 6.99 | |
| Kura Oncology, Inc. KURA | $15.58M | 0.96 | 730,492 | +281.39% | +$11.5M | 2.77 | |
| Absci Corporation ABSI | $5.82M | 0.91 | 1.02M | New | +$5.82M | 1.03 | |
| Fulcrum Therapeutics, Inc. FULC | $5.2M | 0.89 | 550,339 | +340.27% | +$4.02M | 0.92 | |
| Vera Therapeutics, Inc. VERA | $20.27M | 0.86 | 470,000 | New | +$20.27M | 3.6 | |
| Savara Inc. SVRA | $5.73M | 0.83 | 1.15M | 0% | +$0 | 1.02 | |
| Mersana Therapeutics, Inc. MRSN | $4.48M | 0.82 | 1M | 0% | +$0 | 0.8 | |
Perspective Therapeutics, Inc. CATX | $6.07M | 0.8 | 5.1M | New | +$6.07M | 1.08 | |
| Celldex Therapeutics, Inc. CLDX | $21.4M | 0.77 | 510,000 | +27.5% | +$4.62M | 3.8 | |
| Centessa Pharmaceuticals plc CNTA | $9.39M | 0.74 | 830,546 | +4.38% | +$393,432.11 | 1.67 | |
| Terns Pharmaceuticals, Inc. TERN | $2.95M | 0.7 | 450,000 | +581.82% | +$2.52M | 0.52 | |
Mineralys Therapeutics, Inc. MLYS | $4.23M | 0.66 | 327,959 | New | +$4.23M | 0.75 | |
| Establishment Labs Holdings Inc. ESTA | $8.38M | 0.6 | 164,589 | -27.9% | -$3.24M | 1.49 | |
| Crinetics Pharmaceuticals, Inc. CRNX | $22M | 0.6 | 470,000 | +5.12% | +$1.07M | 3.91 | |
| Arcellx, Inc. ACLX | $20.86M | 0.56 | 300,000 | -11.77% | -$2.78M | 3.71 | |
| Madrigal Pharmaceuticals, Inc. MDGL | $30.71M | 0.54 | 115,000 | +15% | +$4.01M | 5.45 | |
| Cullinan Oncology, Inc. CGEM | $4.41M | 0.45 | 258,588 | -13.8% | -$705,660.56 | 0.78 | |
| Morphic Holding, Inc. MORF | $7.92M | 0.45 | 225,000 | +427.3% | +$6.42M | 1.41 | |
| Geron Corporation GERN | $8.25M | 0.42 | 2.5M | New | +$8.25M | 1.47 | |
Immatics N.V. IMTX | $3.68M | 0.34 | 350,000 | +75% | +$1.58M | 0.65 | |
| Mirum Pharmaceuticals, Inc. MIRM | $4.02M | 0.34 | 160,000 | +220% | +$2.76M | 0.71 | |
| Inari Medical, Inc. NARI | $8.4M | 0.3 | 175,000 | +775% | +$7.44M | 1.49 | |
| Axsome Therapeutics, Inc. AXSM | $11.15M | 0.29 | 139,758 | +179.52% | +$7.16M | 1.98 | |
| Nuvalent, Inc. NUVL | $11.26M | 0.23 | 150,000 | -14.29% | -$1.88M | 2 | |
| Immunovant, Inc. IMVT | $9.21M | 0.2 | 285,000 | -17.39% | -$1.94M | 1.64 | |
| Protagonist Therapeutics, Inc. PTGX | $2.89M | 0.17 | 100,000 | New | +$2.89M | 0.51 | |
Cerevel Therapeutics Holdings, Inc. CERE | $12.68M | 0.17 | 300,000 | -60% | -$19.02M | 2.25 | |
| Apellis Pharmaceuticals, Inc. APLS | $9.7M | 0.14 | 165,000 | +120% | +$5.29M | 1.72 | |
SpringWorks Therapeutics, Inc. SWTX | $4.92M | 0.14 | 100,000 | 0% | +$0 | 0.87 | |
| Teva Pharmaceutical Industries Limited TEVA | $19.75M | 0.12 | 1.4M | -26.32% | -$7.05M | 3.51 | |
MoonLake Immunotherapeutics MLTX | $3.77M | 0.12 | 75,000 | +5.65% | +$201,522.76 | 0.67 | |
| Arrowhead Pharmaceuticals, Inc. ARWR | $3.43M | 0.1 | 120,000 | New | +$3.43M | 0.61 | |
| Krystal Biotech, Inc. KRYS | $4.76M | 0.09 | 26,746 | +6.98% | +$310,665.79 | 0.85 | |
| Vaxcyte, Inc. PCVX | $5.46M | 0.07 | 80,000 | +220% | +$3.76M | 0.97 | |
| Cytokinetics, Incorporated CYTK | $5.61M | 0.07 | 80,000 | -50% | -$5.61M | 1 | |
| Roivant Sciences Ltd. ROIV | $5.27M | 0.06 | 500,000 | 0% | +$0 | 0.94 | |
| Intra-Cellular Therapies, Inc. ITCI | $3.46M | 0.05 | 50,000 | New | +$3.46M | 0.61 | |
| Viking Therapeutics, Inc. VKTX | $4.1M | 0.05 | 50,000 | -83.33% | -$20.5M | 0.73 | |
| BeiGene, Ltd. BGNE | $12.85M | 0.01 | 82,143 | New | +$12.85M | 2.28 |